Chan Kam Tim Michael is a practicing private Dermatologist in Hong Kong. He has received his Fellowship from Hong Kong Academy of Medicine (FHKAM) as a Registered
Dermatologist since 1998. He has received his Post-doctoral training in University of California, Los Angeles (UCLA) in 1997. He is presently the Vice President of
the Association of Integrative Aesthetic Medicine (AIAM) in Hong Kong. He serves as an Editorial Board Member of the following International Journal: Journal of Anatomy
and Physiological Studies, The Cognitive Neuroscience Journal, The Research Journal of the Nervous System, since 2017. He has been the Editor of Hong Kong Journal
of Dermatology and Venereology from 2002 to 2007.
Germaine Escames has broad experience in the studies of the antioxidative role of melatonin and the identification of the mitochondria as the main target of melatonin, and its anti-inflammatory activity against the innate immune response, among others. From several years to date, her activity has been focused on the oncostatic activity of melatonin and the adverse effects of radio and chemotherapy. In addition, she studied the effects of melatonin on the skin. She has four international patents on melatonin: one is currently under a multicentric clinical trial (in 10 hospitals of Spain) for the prevention and healing of oral mucositis induced by radio and/or chemotherapy, and other two patents consist in a endovenous melatonin formulation for the treatment of sepsis. The fourth patent consists in a regenerative and anti-aging cream of melatonin for its topic application in the skin. A clinical trial with this cream to treat position ulcers is now being carried out in collaboration with other groups.
CEO of Nanorx INC has a Ph.D. in Organic Chemistry from Oregon State University(1979) and M.S in Chemistry(1972) from I.I.T Mumbai, India. He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim. He has over 25 US and International patents and another 15 pending patent applications.
Prof Liza Bornman completed a PhD in Human Genetics at the University of Pretoria and two Commonwealth Fellowships at the Wellcome Trust Centre for Human Genetics, University of Oxford. Her research interest is the field of epigenetic epidemiology, involving the integration of genetics, epigenetics and environment to influence phenotype. Vitamin D signaling, a model of gene-environment interaction, which is hindered in cancer and infectious diseases, is the focus of her research. She has a Scopus h-index of 16, is the author and co-author of 34 publications and elicited 770 citations.
Liza Bornman(Research Area)
epigenetic epidemiology, involving the integration of genetics, epigenetics and environment to influence phenotype
Dr. Shigehiko Kawakami is a Professor Emeritus, Kanazawa Medical University, director of Kanazawa Medical University and Chairman of Board Directors, Japanese Society of Pressure Ulcers.He is graduated from Kanazawa University School of Medicine, Kanazawa, Japan and got a Medical doctor degree from Department of Plastic and Reconstructive Surgery, Kanazawa Medical University, Uchinada, Japan, he is specialised in Cranio-maxillo-facial surgery, Cleft lip & palate, Wound healing and Skin tumor.